Silence Therapeutics Plc (SLN)
6.37
+0.14
(+2.25%)
USD |
NASDAQ |
Dec 19, 16:00
6.33
-0.04
(-0.63%)
After-Hours: 20:00
Silence Therapeutics Total Assets (Quarterly): 146.79M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Autolus Therapeutics Plc | 661.95M |
| Adaptimmune Therapeutics Plc | 130.63M |
| Mereo BioPharma Group Plc | 53.60M |
| NuCana Plc | 43.50M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 72.73M |
| Shareholders Equity (Quarterly) | 74.06M |
| Debt to Equity Ratio | 0.0025 |
| Current Ratio | 7.689 |
| Net Debt Paydown Yield | 0.01% |